Earnings call: CytomX updates on Probody platform and financial health By Investing.com
[ad_1] © Reuters. CytomX Therapeutics (ticker: NASDAQ:), a biopharmaceutical company, provided a detailed update on their proprietary Probody therapeutic platform and its product candidates during...
Earnings call: Ramaco Resources aims to double met coal production By Investing.com
[ad_1] © Reuters. In a recent earnings call, Ramaco Resources (NASDAQ:) reported a strong finish to the year with record quarterly earnings and ambitious plans...
Earnings call: Extendicare reports strong Q4 growth and strategic progress By Investing.com
[ad_1] © Reuters. Extendicare Inc. (EXE.TO), a provider of care services, announced robust financial results for the fourth quarter of 2023, emphasizing significant growth in...
Earnings call: Smith & Wesson sees growth in Q3, aims for debt-free year-end By Investing.com
[ad_1] © Reuters. Smith & Wesson Brands, Inc. (SWBI) has reported a notable increase in net sales and market share during the third quarter of...
Earnings call: DXP Enterprises celebrates record FY2023, eyes future growth By Investing.com
[ad_1] © Reuters. DXP Enterprises (NASDAQ:) reported a record-breaking fiscal year 2023, with a 13.4% increase in sales totaling $1.7 billion and an adjusted EBITDA...
Earnings call: Merck foresees return to growth in 2024 despite challenges By Investing.com
[ad_1] © Reuters. Merck & Co. Inc. (MRK) reported a mixed performance in its fourth-quarter earnings call for 2023, with a notable decline in net...
Earnings call: AirBoss of America outlines strategic shift amid Q4 decline By Investing.com
[ad_1] © Reuters. AirBoss of America Corp. (BOS.TO) has disclosed its financial results for the fourth quarter and the full year of 2023, revealing a...
Earnings call: Evogene reports robust growth and strategic partnerships By Investing.com
[ad_1] © Reuters. Evogene Ltd . (NASDAQ: NASDAQ:) has reported a significant increase in its annual revenue, rising from $1.7 million in 2022 to approximately...
Earnings call: Real Brokerage announces record Q4 results, plans fintech launch By Investing.com
[ad_1] © Reuters. Real Brokerage Inc. (REAL) has announced a record-breaking fourth quarter, with revenues soaring by 89% to $181 million, marking a robust end...
Earnings call: Credo reports mixed Q3 results, eyes long-term growth By Investing.com
[ad_1] © Reuters. Credo (ticker not provided), a provider of high-speed connectivity solutions, announced its fiscal 2024 third-quarter earnings with mixed results. The company reported...